<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-16T09:42:28Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/7h542vn7fx.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/7h542vn7fx.1</identifier>
                <datestamp>2026-06-01T15:07:50Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>S, Sowmiya </dc:creator>
    <dc:title>ESG-ORIENTED ALTERNATIVE FUELS RESEARCH FACILITY (AFRF)  METHODOLOGY FOR SUSTAINABLE WASTE MANAGEMENT IN  PHARMACEUTICAL MANUFACTURING</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Pharmaceutical manufacturing generates complex hazardous waste streams, including expired drugs, 
effluent treatment plant (ETP) sludge, spent solvents, used oils, and off-specification products, 
posing significant environmental, social, and governance (ESG) challenges. Conventional disposal 
methods such as incineration and landfilling result in emissions, leachate generation, and resource 
loss. This study proposes an Alternative Fuels Research Facility (AFRF) methodology that integrates 
waste segregation, pre-treatment, thermal conversion (pyrolysis, gasification, distillation, and 
controlled incineration), and digital traceability using IoT and blockchain. HAZOP and FMEA were 
conducted for process safety. Results demonstrate 72% overall energy recovery efficiency, 90% 
waste volume reduction, 78% solvent recovery, 61% reduction in greenhouse gas emissions, and 
88% reduction in landfill dependency. ESG performance improved across all pillars (Environmental 
+86%, Social +61%, Governance +87%). The AFRF offers a scalable, economically viable pathway 
(3.5-year payback) toward circular economy practices in the pharmaceutical industry</dc:description>
    <dc:subject>Industrial Chemicals Regulation</dc:subject>
    <dc:subject>Sustainability Assessment</dc:subject>
    <dc:subject>Alternative Fuel</dc:subject>
    <dc:subject>Environmental Social Issue</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/7h542vn7fx.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/7h542vn7fx.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/7h542vn7fx</dc:relation>
    <dc:date>2026-06-01T15:07:50Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
